Publication | Open Access
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
70
Citations
14
References
2023
Year
Phase 1BUrologyGenitourinary CancerMedicineClinical TrialsImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncologyLow-dose Preoperative IpilimumabNabucco Trial
| Year | Citations | |
|---|---|---|
Page 1
Page 1